European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure
Status:
Terminated
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, tolerability and safety of dronedarone
versus placebo in patients with symptomatic congestive heart failure (CHF) and left
ventricular dysfunction (LVD) when added to evidence based treatments for CHF.